SecBot SecBot
8-K ·Filed May 6, 2026

OSUR

ORASURE TECHNOLOGIES INC
BEARISH
Impact 6/10
Horizondays Processed6mo ago SEC0001116463-26-000037
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

Continued revenue decline and widening losses keep OSUR under near-term pressure. Monitor Q2 results for revenue stabilization and upcoming FDA decisions (CT/NG self-test, Colli-Pee) for potential catalysts.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$3.13
T+0 close · May 6, 2026 · via day close
Latest settled
+32.91%
T+60 · $4.16
Vs SPY
+29.07%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 7 $3.13entry
  2. T+1 · 6mo ago −2.24%α −3.07% · $3.06
  3. T+5 · 6mo ago −2.88%α −4.38% · $3.04
  4. T+20 · 6mo ago +26.20%α +23.06% · $3.95
  5. T+60 · 4mo ago +32.91%α +29.07% · $4.16

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

OraSure reported Q1 2026 revenue of $27.9M, down 7% YoY, and a GAAP EPS loss of $0.32, wider than the prior year's $0.21 loss. Gross margin improved to 42.3%, and core business (ex-COVID) was nearly flat, but operating losses grew to $23.3M. Q2 guidance of $27M-$30M revenue signals continued stabilization but no near-term profitability.

Key Financial Metrics

EPS
−$0.32
Revenue
$27.9M
-7.0% YoY
Rating
miss
Guidance
$27M-$30M
maintained
Gross Margin
42.3%

Key Facts

  • Q1 2026 revenue $27.9M (-7% YoY)
  • GAAP EPS -$0.32 vs -$0.21 YoY
  • Gross margin 42.3% vs 41.1% YoY
  • Operating loss $23.3M vs $17.8M YoY
  • Cash & equivalents $177M; repurchased $5M in stock
  • Q2 2026 revenue guidance $27M-$30M

Financial Impact

Revenue declined 7% YoY to $27.9M; net loss widened 40% to $22.4M

revenueepsoperating_incomenet_income

Risk Factors

  • Sustained top-line contraction
  • Cash burn rate despite $177M cash
  • Regulatory/approval delays for pipeline products

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001116463-26-000037
Exhibit: ex992_q1-26investorupdat.htm0001116463-26-000037
Document: osur-20260506.htm0001116463-26-000037
Document: 0001116463-26-000037-index-headers.html0001116463-26-000037
Document: 0001116463-26-000037-index.html0001116463-26-000037
Document: 0001116463-26-000037.txt0001116463-26-000037
8-K Data (Synthetic)0001116463-26-000037

Track record

20 reports on OSUR

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +39.73% at T+60 after the Mar 13, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago 10-Q/A Neutral 2/10 Entry $3.62 to $3.62 Now $3.60 −0.55% · 0.00% +0.36% vs SPY
  2. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $3.33 to $3.56 Now $3.60 +8.11% ▲ +6.91% +5.59% vs SPY
  3. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $3.53 to $3.33 Now $3.60 +1.98% ▼ −5.67% −5.30% vs SPY
  4. Nov 2, 202614d ago Press Release Neutral 2/10 Entry $3.46 to $3.53 Now $3.60 +4.20% ▲ +2.17% +1.87% vs SPY
  5. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $3.94 to $3.46 Now $3.60 −8.63% ▼ −12.31% −11.83% vs SPY
  6. Sep 17, 20268w ago SC 13D Bullish 6/10 Entry $3.56 to $3.69 Now $3.60 +1.12% ▲ +3.65% +2.10% vs SPY
  7. Jul 23, 202616w ago Court Ruling Neutral 3/10 Entry $3.97 to $3.96 Now $3.60 −9.32% ▼ −0.25% −0.27% vs SPY
  8. Jun 12, 202622w ago Institutional Cluster Mixed 4/10 Entry $4.18 to $4.17 Now $3.60 −13.88% ▼ −0.24% −2.00% vs SPY
  9. Jun 3, 202623w ago 8-K Neutral 3/10 Entry $4.17 to $4.04 Now $3.60 −13.67% ▼ −3.12% −0.52% vs SPY
  10. May 6, 202627w ago 8-K Bearish 6/10 Viewing Entry $3.13 to $3.06 Now $3.60 −15.02% ▲ +2.24% +3.07% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 6, 2026